Diluted Deodorized Tincture of Opium — Competitive Intelligence Brief

Diluted Deodorized Tincture of Opium (Diluted Deodorized Tincture of Opium) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Opioid agonist. Area: Pain management, Gastroenterology.

marketed Opioid agonist Mu opioid receptor (primary), delta opioid receptor, kappa opioid receptor Pain management, Gastroenterology Small molecule

Target snapshot

Diluted Deodorized Tincture of Opium (Diluted Deodorized Tincture of Opium) — Eastern Maine Medical Center. Diluted Deodorized Tincture of Opium (DDO) is an opioid preparation that binds to opioid receptors in the central and peripheral nervous system to produce analgesia and antidiarrheal effects.

Comparator set (6 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Diluted Deodorized Tincture of Opium TARGET	Diluted Deodorized Tincture of Opium	Eastern Maine Medical Center	marketed	Opioid agonist	Mu opioid receptor (primary), delta opioid receptor, kappa opioid receptor
BENZHYDROCODONE	BENZHYDROCODONE		marketed	Opioid analgesic combination; full mu-opioid agonist with non-opioid analgesic	Mu-opioid receptors (primary); delta and kappa opioid receptors (secondary); central nervous system pain pathways	2018-01-01
Nucynta	TAPENTADOL	Collegium Pharm Inc	marketed	Opioid Agonist	Mu-type opioid receptor	2008-01-01
Alfenta	ALFENTANIL	Rising	marketed	Opioid Agonist	Mu-type opioid receptor	1986-01-01
Sufenta Preservative Free	SUFENTANIL	Rising	marketed	Opioid Agonist	Mu-type opioid receptor	1984-01-01
Dilaudid-Hp	Hydromorphone Hydrochloride	Fresenius Kabi	marketed	Opioid agonist	Mu-opioid receptor	1984-01-01
Dilaudid-Hp	HYDROMORPHONE	Fresenius Kabi	marketed	Opioid Agonist	mu-opioid receptor	1984-01-01

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Opioid agonist class)

1. University of British Columbia · 3 drugs in this class
2. Ciusss de L'Est de l'Île de Montréal · 2 drugs in this class
3. Kaohsiung Veterans General Hospital. · 2 drugs in this class
4. Nycomed · 2 drugs in this class
5. Rigshospitalet, Denmark · 2 drugs in this class
6. University Hospital, Ghent · 2 drugs in this class
7. Fundación Universitaria de Ciencias de la Salud · 2 drugs in this class
8. Erasme University Hospital · 2 drugs in this class
9. Cephalon · 2 drugs in this class
10. Corporacion Parc Tauli · 1 drug in this class